Related Experiment Video
Updated: Jun 1, 2025

The Tail Suspension Test
Published on: January 28, 2012
Kidney function decline improves after lithium discontinuation
Filip Fransson1, Ursula Werneke2, Louise Öhlund2
1Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Background:
Long-term lithium treatment decreases kidney function. However, it remains unclear whether stopping lithium improves kidney function.
Objectives:
To study kidney function in patients who stopped and subsequently restarted lithium treatment.
Methods:
Mirror-image design using data from the LiSIE retrospective cohort study. The mirror was set to when lithium was stopped with a 5-year pre- and post-mirror period. Adult patients with bipolar, schizoaffective disorder or unipolar depression, who had lithium ≥4.5 years in the pre-mirror period, were included. Creatinine measurements were available from 1997 to 2017. The main outcome was the difference in mean annual change of the estimated glomerular filtration rate (eGFR) adjusted for sex, hypertension and diabetes mellitus.
Results:
A total of 168 participants (94 women, 74 men) were included. Mean annual eGFR change was -1.58 (-1.87 to -1.28) mL/min/1.73 m2/year before and -0.023 (-0.49 to +0.44) mL/min/1.73 m2/year after lithium discontinuation (p < 0.0001 for difference). The improvement was 0.77 (0.35-1.20) mL/min/173 m2/year in participants with eGFR >60 mL/min/1.73 m2, and 3.03 (2.15-3.92) mL/min/1.73 m2/year for participants with eGFR <30 mL/min/1.73 m2. The effect was persistent over the 5-year post-mirror study period. For participants restarting lithium, the mean annual eGFR change was -1.71 (-2.26 to -1.16) mL/min/1.73 m2/year, a setback compared to their lithium-free post-mirror period (p < 0.0001). We did not see any difference compared to the pre-mirror period (p = 0.51).
Conclusions:
Stopping lithium slowed down mean eGFR decline. This effect was more pronounced in participants with lower eGFR at the time of lithium discontinuation. In participants who restarted lithium, the annual decline of eGFR reverted to pre-lithium discontinuation levels.
More Related Videos
Related Concept Videos
Mania and Antimanic Drugs: Overview
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Elimination by Renal Route: Tubular Reabsorption
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antihypertensive Drugs: Potassium-Sparing Diuretics

